The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Anti-TNF Roundup: The latest on these treatments for autoimmune conditions
August 9th 2019In this slideshow we provide a quick update on the latest developments the anti-TNF treatments of rheumatoid arthritis, psoriatic arthrhitis, ankylosing spondylitis and other autoimmune conditions. Among the developments includes a new surprising use for etanercept (Enbrel, Amgen).
Are radiographic axSpA and ankylosing spondylitis one in the same?
August 6th 2019The established criteria for radiographic axial spondyloarthritis and axial spondyloarthritis that is classified as ankylosing spondylitis-is essentially the same, report physicians who recommend the interchangeable use of the terms "ankylosing spondylitis" and "radiographic axial spondyloarthritis."
Periodontal Disease Precedes Rheumatoid Arthritis Diagnosis
August 6th 2019Periodontal disease and periodontal inflammation appear to be present in individuals who are at risk of developing rheumatoid arthritis long before they begin to show signs of disease, shows new research published in JAMA Network Open.
What’s next for rheumatoid arthritis-associated periodontal disease?
August 6th 2019Identifying and treating symptoms that can appear years before the clinical onset of rheumatoid arthritis could play a role in helping patients offset the condition. And now, new research that identifies a bacteria as a potential cause of these symptoms has one rheumatologist positing whether improved oral care, or maybe a vaccine, might be effective in preventing rheumatoid arthritis.
The Burden of Comorbidities Weigh Differently on PsA and AS Patients
August 1st 2019High levels of comorbidity burden are associated independently with poor physical function and increased disability in patients with psoriatic arthritis, however, patients ankylosing spondylitis did not report worse function when comorbidities were present.
Pitfalls Associated with Diagnosing Polymyalgia Rheumatica and Fibromyalgia in Young Obese Patients
July 30th 2019Fibromyalgia and polymyalgia rheumatica are distinctly different, but in a case report described in the May 8 issue of the American Journal of Case Reports, Fawad Aslam, M.D., of Mayo Clinic in Arizona, and colleagues describe a confusing case of a 30-year-old woman.
Infection risk high in polymyalgia rheumatica and giant cell arteritis, plus more new findings
July 30th 2019In this sideshow, we highlight recent advances from vitamin D's role in autoimmune conditions to the combination diagnosis of polymyalgia rheumatica and giant cell arteritis. Learn more in this slideshow.
Some Scleroderma Patients are Protected from Cancer
July 28th 2019Researchers writing in Arthritis and Rheumatology have found that some scleroderma patients carry enriched antibodies that may prevent cancer and provide immunity to other systemic sclerosis-associated conditions, such as scleroderma renal crisis and SSc-gastrointestinal disease.
9 Fast New Facts about Knee Replacement
July 26th 2019Recent advances in partial and total knee arthroplasty show that taking essential amino acids may improve outcomes post-surgery; more patients may be having physical therapy with a virtual reality game instead of a physical therapist; and, a Florida hospital experiments with bundled care for arthroplasty procedures. Learn more in this slideshow.
New Treatment Option for Behçet’s Disease
July 22nd 2019On Friday, the U.S. Food and Drug Administration approved apremilast (Otezla, Celgene) for the treatment of oral ulcers associated with Behçet’s disease, a rare, chronic, multisystem inflammatory condition that affects approximately five in 100,000 people in the U.S.
EULAR Updates Guidelines for Large Vessel Vasculitis
July 19th 2019The European League Against Rheumatism has updated treatment guidelines for the management of large vessel vasculitis. Among the changes, the task force no longer recommends the routine use of antiplatelet or anticoagulant therapy. Learn more in this slideshow.